Christian Plank

USPTO Granted Patents = 13 (Patent Applications = 8)

CIPO Patents = 4 (Patent Applications = 2)

EPO Patents = 8 (Patent Applications = 14)

Average Co-Inventor Count = 4.5

ph-index = 3

Forward Citations = 61(Granted Patents)

Location History:

Martinsried, DE (2015 - 2021)
Planegg, DE (2019 - 2022)
Wessling, DE (2017 - 2024)
Seefeld, DE (2021 - 2024)

Company Filing History:

Shire Human Genetic Therapies, Inc.

patents

4. 1 out of 4

Rana Therapeutics, Inc.

patents

where one patent can have more than one assignee

Years Active: 2015-2025

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12263229 - Induction of osteogenesis by delivering BMP encoding RNA (2025-04-01),

2. 12064484 - Compositions for introducing RNA into cells (2024-08-20),

3. 11981910 - Minimal UTR sequences (2024-05-14),

4. 11510937 - CFTR MRNA compositions and related methods and uses (2022-11-29),

5. 11479768 - ATP-binding cassette family coding polyribonucleotides and formulations thereof (2022-10-25),

6. 11352638 - Minimal UTR sequences (2022-06-07),

7. 11090264 - Pulmonary delivery of mRNA to non-lung target cells (2021-08-17),

8. 11020487 - Compositions for introducing nucelic acid into cells (2021-06-01),

9. 10927383 - Cas9 mRNAs (2021-02-23),

10. 10420791 - CFTR MRNA compositions and related methods and uses (2019-09-24),

11. 10245229 - Pulmonary delivery of mRNA to non-lung target cells (2019-04-02),

12. 9713626 - CFTR mRNA compositions and related methods and uses (2017-07-25),

13. 9181321 - CFTR mRNA compositions and related methods and uses (2015-11-10),

Title: Christian Plank: Pioneering Innovations in RNA Delivery

Introduction

Christian Plank, an accomplished inventor based in Wessling, Germany, has made significant contributions to the field of molecular biology through his 12 patents. His work focuses on innovative technologies for introducing RNA into cells, which play a crucial role in advancing therapeutic options.

Latest Patents

Among his latest inventions are two noteworthy patents. The first is related to "Compositions for Introducing RNA into Cells." This invention encompasses oligomers, polymers, and lipidoids featuring oligo(alkylene amine) moieties, which function effectively as vehicles for transfecting cells with RNA. Additionally, the patent outlines a composition that combines a nucleic acid and these oligomeric or polymeric elements, along with methods for cellular transfection using the described compositions. Furthermore, it discusses pharmaceutical compositions and their applications.

The second patent is focused on "Minimal UTR Sequences." This invention describes DNA molecules that can be transcribed into mRNA with novel UTR sequences. These sequences are designed to be extremely short while maintaining high translation efficiencies of RNA molecules. The patent also covers vectors that contain these DNA molecules and the host cells that utilize them. It explores the various pharmaceutical compositions involving the described RNA molecules and the use of these UTRs in translating coding regions into polypeptides or proteins.

Career Highlights

Christian Plank has had an impactful career, having worked with notable companies such as Ethris GmbH and Translate Bio, Inc. His expertise and innovative mindset have solidified his standing as a key figure in the field of RNA research.

Collaborations

Throughout his career, Christian has collaborated with esteemed colleagues, including Carsten Rudolph and Michael W. Heartlein. These partnerships have allowed him to further push the boundaries of innovation in biotechnology.

Conclusion

Christian Plank remains a prominent inventor in RNA technology, consistently driving forward his research and innovations. His contributions have the potential to revolutionize therapeutic strategies, establishing a lasting legacy in the realm of molecular biology and medical applications.

This text is generated by artificial intelligence and may not be accurate.